Journal
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
Volume 11, Issue 3, Pages 214-221Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1995-7645.228436
Keywords
Chikungunya virus; Andrographolide; Interferon alpha; Protein kinase R; Retinoic acid inducible gene-I; Tumor necrosis factor alpha
Funding
- Defence Research & Development Organization (DRDO)
Ask authors/readers for more resources
Objective: To investigate the therapeutic efficacy of andrographolide, a plant derived compound, against chikungunya virus (CHIKV) infection. Methods: Using flow cytometry and immunoblotting assay, in vitro viral protein expression was studied in THP-1 cells line. In Balb/c mouse neonates, viral RNA copy number was determined by real time PCR. Results: The results showed reduced CHIKV protein expression on andrographolide treatment in CHIKV-infected human peripheral blood mononuclear cells, Vero cells and THP-1 cell line. In vivo, andrographolide treatment to CHIKV-infected neonates reduced viral RNA copy number. Further, andrographolide also increased cytotoxic T lymphocytes both in vitro and in vivo. Andrographolide also activated host innate immune pathways, viz., protein kinase R, phosphorylated eukaryotic initiation factor 2 alpha, retinoic acid inducible gene-I and interferon regulatory factor 3/7, thereby increasing IFN-alpha secretion. CHIKV-induced nuclear factor kappa light chain enhancer of activated B cells and tumor necrosis factor-alpha was also reduced on andrographolide treatment. Conclusion: Andrographolide inhibits CHIKV by suppressing viral protein expression and up-regulating host innate immunity and hence could be an effective therapeutic agent against CHIKV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available